Abaxis Inc Receivables Turnover Ratio (ABAX), from the fourth quarter 2018 to the fourth quarter 2017 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Abaxis Inc  (ABAX)
 

Abaxis Inc Accounts Receivables Turnover Ratio from the fourth quarter 2018 to the fourth quarter 2017

Quarterly Results, Trends, Rankings, Statistics


Abaxis Inc's ability to collect accounts receivable sequentially worsen to 5.65, indicating more challenging environment then in the third quarter 2018, but still, it is a far cry from any concerns. Abaxis Inc's Accounts Receivable average collection period in the Mar 31 2018 quarter, has increased to 65 days, from 64 days, in the Dec 31 2017 quarter.

If we take a look into Healthcare sector 180 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2018 from 1600 to 1848.

What is Receivable Turnover Ratio?
What is Abaxis Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ABAX Receivables Turnover Ratio (Mar 31 2018)
IV. Quarter		 (Dec 31 2017)
III. Quarter		 (Sep 30 2017)
II. Quarter		 (Jun 30 2017)
II. Quarter		 (Mar 31 2017)
IV. Quarter
Y / Y Receivable Change 18.72 % 14.6 % 15.44 % 19.27 % 15.42 %
Y / Y Revenue Change 16.7 % 13.07 % 0.52 % 0.97 % 2.18 %
Receivable Turnover Ratio (TTM) 5.65 5.67 5.68 5.87 6.14
ABAX's Total Ranking # 1848 # 1600 # 2459 # 1500 #
Accounts Receivable average collection period days 65 64 64 62 59
Seq. Receivable Change 19.24 % -0.79 % -7.51 % 8.51 % 15.1 %
Seq. Revenue Change 13.82 % 1.39 % 1.02 % 0.1 % 10.29 %


Receivable Turnover Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 10
Healthcare Sector # 181
Overall Market # 1848

Receivable Turnover Ratio Statistics
High Average Low
0.94 0.84 0.74
(Mar 31 2013)   (Sep 30 2017)





ABAX Company Profile • Back to ABAX Efficiency Comparisons • Compare ABAX Receivables Turnover Ratio to its Competitors

Financial Statements
Abaxis Inc's Accounts Receivable $ 48 Millions Visit ABAX's Balance sheet
Abaxis Inc's Sales TTM $ 245 Millions Visit ABAX's Income Statement
Sources of ABAX's Revenues Visit ABAX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ABAX's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ABAX's Growth Rates ABAX's Roa ABAX's Inventory Turnover Ratio ABAX's Dividend Comparisons
ABAX's Profitability Ratios ABAX's Roi ABAX's Asset Turnover Ratio ABAX's Dividend Growth
ABAX's Valuation Ratios ABAX's Roe ABAX's Financial Strength Ratios ABAX's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2018, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2018 Receivable at quarter ending Mar 31 2018
Harrow Inc   13.93 $ 29.542  Millions$ 2.121  Millions
Heartbeam Inc   13.60 $ 325.391  Millions$ 23.929  Millions
Clovis Oncology inc   13.23 $ 66.989  Millions$ 5.065  Millions
Sangamo Therapeutics Inc   13.23 $ 45.779  Millions$ 3.462  Millions
Kushco Holdings Inc   13.13 $ 32.565  Millions$ 2.479  Millions
Dmk Pharmaceuticals Corporation  13.10 $ 13.215  Millions$ 1.009  Millions
Timber Pharmaceuticals Inc   13.09 $ 0.072  Millions$ 0.006  Millions
Bioxytran Inc   12.86 $ 0.197  Millions$ 0.015  Millions
Caredx Inc   12.86 $ 50.793  Millions$ 3.951  Millions
Abeona Therapeutics Inc   12.47 $ 1.182  Millions$ 0.095  Millions
Chinook Therapeutics Inc   12.42 $ 20.094  Millions$ 1.618  Millions
Guardion Health Sciences Inc   12.39 $ 0.574  Millions$ 0.046  Millions
Integrated Biopharma Inc  12.19 $ 42.392  Millions$ 3.478  Millions
Procyon Corporation  12.17 $ 4.120  Millions$ 0.339  Millions
Icu Medical Inc  12.16 $ 1,416.907  Millions$ 116.549  Millions
Lifeloc Technologies Inc   12.11 $ 8.208  Millions$ 0.678  Millions
International Stem Cell Corporation  12.01 $ 8.084  Millions$ 0.673  Millions
Travere Therapeutics Inc   11.68 $ 159.749  Millions$ 13.679  Millions
Kineta Inc   11.64 $ 5.262  Millions$ 0.452  Millions
Logicmark Inc  11.60 $ 20.108  Millions$ 1.733  Millions
Akebia Therapeutics Inc   11.59 $ 203.049  Millions$ 17.517  Millions
Theravance Biopharma inc   11.54 $ 20.618  Millions$ 1.787  Millions
Crispr Therapeutics Ag  11.40 $ 39.652  Millions$ 3.478  Millions
Exact Sciences Corporation  11.39 $ 307.922  Millions$ 27.035  Millions
Teladoc Health Inc   11.31 $ 280.025  Millions$ 24.755  Millions
Sunlink Health Systems Inc   11.27 $ 52.946  Millions$ 4.696  Millions
Icagen, Inc.  11.07 $ 19.918  Millions$ 1.799  Millions
Davita Inc   11.05 $ 21,236.763  Millions$ 1,922.557  Millions
Zynex inc   11.01 $ 26.872  Millions$ 2.442  Millions
Biolife Solutions Inc   10.86 $ 12.471  Millions$ 1.148  Millions

Date modified: 2026-10-07T00:41:37+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.